Shattuck Labs Inc Q3 2024 Earnings Revenue Soars to 3.0M, EPS Loss of 0.33 Beats Estimates
STTK Stock | USD 1.44 0.47 24.61% |
About 65% of Shattuck Labs' investor base is looking to short. The analysis of the overall investor sentiment regarding Shattuck Labs suggests that many traders are alarmed. Shattuck Labs' investing sentiment shows overall attitude of investors towards Shattuck Labs.
Shattuck |
Revenue 3.0 million for Q3 2024, significantly surpassing the analyst estimate of 0.65 million.Net Loss 16.7 million for Q3 2024, or 0.33 per share, show
Read at gurufocus.com
![]() |
Shattuck Labs Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Shattuck Labs can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Shattuck Labs Fundamental Analysis
We analyze Shattuck Labs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shattuck Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shattuck Labs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Shattuck Labs is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Shattuck Labs Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Shattuck Labs stock to make a market-neutral strategy. Peer analysis of Shattuck Labs could also be used in its relative valuation, which is a method of valuing Shattuck Labs by comparing valuation metrics with similar companies.
Peers
Shattuck Labs Related Equities
CSBR | Champions Oncology | 7.10 | ||||
PMVP | Pmv Pharmaceuticals | 1.42 | ||||
STOK | Stoke Therapeutics | 0.24 | ||||
GLUE | Monte Rosa | 1.03 | ||||
IPSC | Century Therapeutics | 1.43 | ||||
KYMR | Kymera Therapeutics | 1.70 | ||||
NRIX | Nurix Therapeutics | 2.31 | ||||
PRLD | Prelude Therapeutics | 2.41 | ||||
FHTX | Foghorn Therapeutics | 2.59 | ||||
CCCC | C4 Therapeutics | 5.02 |
Check out Shattuck Labs Hype Analysis, Shattuck Labs Correlation and Shattuck Labs Performance. For more information on how to buy Shattuck Stock please use our How to buy in Shattuck Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shattuck Labs. If investors know Shattuck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shattuck Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share | Quarterly Revenue Growth 3.369 | Return On Assets | Return On Equity |
The market value of Shattuck Labs is measured differently than its book value, which is the value of Shattuck that is recorded on the company's balance sheet. Investors also form their own opinion of Shattuck Labs' value that differs from its market value or its book value, called intrinsic value, which is Shattuck Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shattuck Labs' market value can be influenced by many factors that don't directly affect Shattuck Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shattuck Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shattuck Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shattuck Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.